Twist Bioscience Corp (TWST)

Twist Bioscience (TWST) Financial Statements


Twist Bioscience Financial Overview

Twist Bioscience's market cap is currently ―. The company's EPS TTM is $-3.348; its P/E ratio is -13.15; Twist Bioscience is scheduled to report earnings on August 2, 2024, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 71.50M$ 66.95M$ 63.74M$ 2.20M$ 54.24M
Gross Profit$ 28.96M$ 24.52M$ 63.16M$ -40.47M$ -25.31M
EBIT$ -42.89M$ -46.46M$ -56.77M$ -61.94M$ -44.79M
EBITDA$ -34.72M$ -37.97M$ -54.20M$ -54.91M$ -39.49M
Net Income Common Stockholders$ -43.01M$ -46.27M$ -57.40M$ -59.16M$ -41.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 311.14M$ 336.41M$ 357.14M$ 387.66M$ 438.71M
Total Assets$ 732.82M$ 776.40M$ 810.33M$ 853.92M$ 909.97M
Total Debt$ 91.88M$ 94.07M$ 93.03M$ 91.22M$ 93.97M
Net Debt$ -219.27M$ -242.34M$ -264.11M$ -296.44M$ -344.74M
Total Liabilities$ 142.77M$ 152.97M$ 152.78M$ 149.99M$ 163.65M
Stockholders Equity$ 590.04M$ 623.43M$ 657.54M$ 703.93M$ 746.33M
Cash Flow-
Free Cash Flow$ -24.48M$ -23.10M$ -27.92M$ -53.34M$ -65.89M
Operating Cash Flow$ -22.97M$ -20.70M$ -23.41M$ -44.29M$ -54.07M
Investing Cash Flow$ 4.17M$ -2.25M$ 18.67M$ 41.16M$ -6.97M
Financing Cash Flow$ -1.47M$ 442.00K$ -661.00K$ 1.52M$ -395.00K
Currency in USD

Twist Bioscience Earnings and Revenue History

Twist Bioscience Debt to Assets

Twist Bioscience Cash Flow

Twist Bioscience Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis